ANTENGENE-B6996.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, ANTENGENE-B (6996.HK) trades at a P/E of 31.40x, P/B of 2.02x, P/S of 3.26x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 11th percentile over the trailing 10Y window (vs. 11th percentile over 3Y); P/B sits at the 55th percentile over the trailing 10Y window (vs. 48th percentile over 3Y); P/S sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 69th percentile within its industry and the 84th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.67%, ranking at the 75th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 43.7 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Shareholder returns here lean heavily on buybacks rather than cash dividends. ANTENGENE-B operates in the Biomedical II sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 6996 · SEHK: 6996 · 6996
Want the full picture on whether ANTENGENE-B (6996.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 31.40 | ||||||
| P/B (MRQ) | 2.02 | ||||||
| P/S (TTM) | 3.26 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.67% |